Central Lab Market (By Product Type: Genetic Services, Biomarker Services, Microbiology Services, Special Chemistry Services, Clinical Research & Trial Services, Others; By End User: Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Central Lab Market
5.1. COVID-19 Landscape: Central Lab Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Central Lab Market, By Product Type
8.1. Central Lab Market, by Product Type, 2024-2033
8.1.1. Genetic Services
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Biomarker Services
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Microbiology Services
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Special Chemistry Services
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Clinical Research & Trial Services
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Central Lab Market, By End User
9.1. Central Lab Market, by End User, 2024-2033
9.1.1. Pharmaceutical Companies
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Biotechnology Companies
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Academic & Research Institutes
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Central Lab Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.1.2. Market Revenue and Forecast, by End User (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.1.3.2. Market Revenue and Forecast, by End User (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.1.4.2. Market Revenue and Forecast, by End User (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.2.2. Market Revenue and Forecast, by End User (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.2.3.2. Market Revenue and Forecast, by End User (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.2.4.2. Market Revenue and Forecast, by End User (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.2.5.2. Market Revenue and Forecast, by End User (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.2.6.2. Market Revenue and Forecast, by End User (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.3.2. Market Revenue and Forecast, by End User (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.3.3.2. Market Revenue and Forecast, by End User (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.3.4.2. Market Revenue and Forecast, by End User (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.3.5.2. Market Revenue and Forecast, by End User (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.3.6.2. Market Revenue and Forecast, by End User (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.4.2. Market Revenue and Forecast, by End User (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.4.3.2. Market Revenue and Forecast, by End User (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.4.4.2. Market Revenue and Forecast, by End User (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.4.5.2. Market Revenue and Forecast, by End User (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.4.6.2. Market Revenue and Forecast, by End User (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.5.2. Market Revenue and Forecast, by End User (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.5.3.2. Market Revenue and Forecast, by End User (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product Type (2021-2033)
10.5.4.2. Market Revenue and Forecast, by End User (2021-2033)
Chapter 11. Company Profiles
11.1. ACM Global Central Lab
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. ICON
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. PPD
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Barc Lab (Cerba Research)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bioscientia (Sonic Healthcare)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Celerion
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. CIRION BioPharma Research
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Clinical Reference Laboratory
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Lab Corp
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Eurofins Central Laboratory
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client